Ovid Therapeutics, Inc. (OVID)

1.65 +0.03 (+1.85%) USD  |  NASDAQ  |  Dec 11, 16:00
1.62 -0.03 (-1.82%) After-Hours: 07:51
More

Ovid Therapeutics Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for OVID.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
AnaptysBio, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MannKind Corp. Upgrade
Cassava Sciences, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade